Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity

FEBS Letters

Volumn 580, Issue 25, 2006, Pages 6015-6021

  Wang, Hui ^a,d   Sun, Xiaoqing ^b   Luo, Ying ^a,b,c   Lin, Zhixin ^a   Wu, Jun ^a,b,c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

^c GNI Ltd   (Japan)

^d FUJIAN NORMAL UNIVERSITY   (China)

Author keywords

AP 1; Jab1; NRBP; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; JUN ACTIVATION DOMAIN BINDING PROTEIN 1; NUCLEAR RECEPTOR BINDING PROTEIN; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EMBRYO; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; NUCLEAR REACTOR; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BINDING SITES; CELL LINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PEPTIDE HYDROLASES; PHOSPHORYLATION; PROTEIN KINASES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TWO-HYBRID SYSTEM TECHNIQUES; VESICULAR TRANSPORT PROTEINS;

MAMMALIA;

EID: 33750035831     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.10.002     Document Type: Article

References (33)

1. Wei N., and Deng X.W. The COP9 signalosome. Trends Genet. 15 (1999) 98-103
2. Bech-Otschir D., Kraft R., Huang X., Henklein P., Kapelari B., Pollmann C., and Dubiel W. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO. J. 20 (2001) 1630-1639
3. Uhle S., Medalia O., Waldron R., Dumdey R., Henklein P., Bech-Otschir D., Huang X., Berse M., Sperling J., Schade R., and Dubiel W. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO. J. 22 (2003) 1302-1312
4. Tomoda K., Kubota Y., Arata Y., Mori S., Maeda M., Tanaka T., Yoshida M., Yoneda-Kato N., and Kato J.Y. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277 (2002) 2302-2310
5. Cope G.A., Suh G.S., Aravind L., Schwarz S.E., Zipursky S.L., Koonin E.V., and Deshaies R.J. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 298 (2002) 608-611
6. Bech-Otschir D., Seeger M., and Dubiel W. The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J. Cell. Sci. 115 (2002) 467-473
7. Spain B.H., Bowdish K.S., Pacal A.R., Staub S.F., Koo D., Chang C.Y., Xie W., and Colicelli J. Two human cDNAs, including a homolog of Arabidopsis FUS6 (COP11), suppress G-protein- and mitogen-activated protein kinase-mediated signal transduction in yeast and mammalian cells. Mol. Cell. Biol. 16 (1996) 6698-6706
8. Lee J.W., Choi H.S., Gyuris J., Brent R., and Moore D.D. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9 (1995) 243-254
9. Dressel U., Thormeyer D., Altincicek B., Paululat A., Eggert M., Schneider S., Tenbaum S.P., Renkawitz R., and Baniahmad A. A a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Mol. Cell Biol. 19 (1999) 3383-3394
10. Claret F.X., Hibi M., Dhut S., Toda T., and Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383 (1996) 453-457
11. Seeger M., Kraft R., Ferrell K., Bech-Otschir D., Dumdey R., Schade R., Gordon C., Naumann M., and Dubiel W. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. Faseb. J. 12 (1998) 469-478
12. Wei N., Tsuge T., Serino G., Dohmae N., Takio K., Matsui M., and Deng X.W. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex. Curr. Biol. 8 (1998) 919-922
13. Chamovitz D.A., and Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO. Rep. 2 (2001) 96-101
14. Tomoda K., Kubota Y., and Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398 (1999) 160-165
15. Jeon J.H., Lee K.N., Hwang C.Y., Kwon K.S., You K.H., and Choi I. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res. 65 (2005) 4485-4489
16. Kleemann R., Hausser A., Geiger G., Mischke R., Burger-Kentischer A., Flieger O., Johannes F.J., Roger T., Calandra T., Kapurniotu A., Grell M., Finkelmeier D., Brunner H., and Bernhagen J. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408 (2000) 211-216
17. Bianchi E., Denti S., Granata A., Bossi G., Geginat J., Villa A., Rogge L., and Pardi R. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404 (2000) 617-621
18. Hooper J.D., Baker E., Ogbourne S.M., Sutherland G.R., and Antalis T.M. Cloning of the cDNA and localization of the gene encoding human NRBP, an ubiquitously expressed, multidomain putative adapter protein. Genomics 66 (2000) 113-118
19. Lim R., Winteringham L.N., Williams J.H., McCulloch R.K., Ingley E., Tiao J.Y., Lalonde J.P., Tsai S., Tilbrook P.A., Sun Y., Wu X., Morris S.W., and Klinken S.P. MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1. J. Biol. Chem. 277 (2002) 40997-41008
20. De Langhe S., Haataja L., Senadheera D., Groffen J., and Heisterkamp N. Interaction of the small GTPase Rac3 with NRBP, a protein with a kinase-homology domain. Int. J. Mol. Med. 9 (2002) 451-459
21. Wu J., Motto D.G., Koretzky G.A., and Weiss A. Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4 (1996) 593-602
22. Chua J.J., Ng M.M., and Chow V.T. The non-structural 3 (NS3) protein of dengue virus type 2 interacts with human nuclear receptor binding protein and is associated with alterations in membrane structure. Virus Res. 102 (2004) 151-163
23. Wei N., and Deng X.W. The COP9 signalosome. Annu. Rev. Cell Dev. Biol. 19 (2003) 261-286
24. Hwang C.Y., Ryu Y.S., Chung M.S., Kim K.D., Park S.S., Chae S.K., Chae H.Z., and Kwon K.S. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Oncogene 23 (2004) 8868-8875
25. Tanaka Y., Kanai F., Ichimura T., Tateishi K., Asaoka Y., Guleng B., Jazag A., Ohta M., Imamura J., Ikenoue T., Ijichi H., Kawabe T., Isobe T., and Omata M. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 25 (2006) 633-642
26. Chauchereau A., Georgiakaki M., Perrin-Wolff M., Milgrom E., and Loosfelt H. JAB1 interacts with both the progesterone receptor and SRC-1. J. Biol. Chem. 275 (2000) 8540-8548
27. Shaulian E., and Karin M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4 (2002) E131-E136
28. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
29. Kouvaraki M.A., Rassidakis G.Z., Tian L., Kumar R., Kittas C., and Claret F.X. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res. 63 (2003) 2977-2981
30. Korbonits M., Chahal H.S., Kaltsas G., Jordan S., Urmanova Y., Khalimova Z., Harris P.E., Farrell W.E., Claret F.X., and Grossman A.B. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. J. Clin. Endocrinol. Metab. 87 (2002) 2635-2643
31. Sui L., Dong Y., Ohno M., Watanabe Y., Sugimoto K., Tai Y., and Tokuda M. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin. Cancer Res. 7 (2001) 4130-4135
32. Ito Y., Yoshida H., Matsuzuka F., Matsuura N., Nakamura Y., Nakamine H., Kakudo K., Kuma K., and Miyauchi A. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Anticancer Res. 23 (2003) 4121-4125
33. Rassidakis G.Z., Claret F.X., Lai R., Zhang Q., Sarris A.H., McDonnell T.J., and Medeiros L.J. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin. Cancer Res. 9 (2003) 1121-1128